What Does the NIPT Test Screen For? Key Genetic Conditions Explained
Learn what the NIPT test screens for, including Down syndrome, Edward syndrome, and Patau syndrome, plus fetal sex and rare disorders safely and non-invasively.
32 views
The NIPT test (Non-Invasive Prenatal Testing) is designed to screen for specific genetic conditions in a fetus by examining small fragments of DNA in the mother's blood. Primarily, it tests for chromosomal abnormalities such as Down syndrome (trisomy 21), Edward syndrome (trisomy 18), and Patau syndrome (trisomy 13). Additionally, NIPT can provide information on the sex of the fetus, and in some cases, rare genetic disorders. It's a safe screening method for both the mother and fetus, offering valuable early insights without the risks associated with invasive testing methods.
FAQs & Answers
- What conditions can the NIPT test detect? The NIPT test primarily detects chromosomal abnormalities such as Down syndrome (trisomy 21), Edward syndrome (trisomy 18), and Patau syndrome (trisomy 13), and can also provide information on fetal sex and rare genetic disorders.
- Is the NIPT test safe for mother and fetus? Yes, the NIPT test is a safe, non-invasive screening method that analyzes fetal DNA fragments in the mother's blood without the risks associated with invasive procedures.
- When is the best time to take the NIPT test during pregnancy? The NIPT test is typically performed after the 10th week of pregnancy, as by this time sufficient fetal DNA circulates in the mother's blood for accurate screening.
- Does the NIPT test provide a definitive diagnosis? No, the NIPT test is a screening tool. Positive or high-risk results usually require confirmatory diagnostic tests such as amniocentesis or chorionic villus sampling.